Free Trial
NASDAQ:RVPHW

Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis

Reviva Pharmaceuticals logo
$0.14 -0.01 (-8.33%)
(As of 12/20/2024 05:16 PM ET)

About Reviva Pharmaceuticals Stock (NASDAQ:RVPHW)

Key Stats

Today's Range
$0.10
$0.15
50-Day Range
$0.09
$0.50
52-Week Range
$0.07
$1.62
Volume
51,596 shs
Average Volume
20,015 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

Receive RVPHW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RVPHW Stock News Headlines

Reviva announces enrollment update for OLE study of brilaroxazine
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Reviva Pharmaceuticals Progresses with Brilaroxazine Study Update
RVPH: RECOVER Biomarker KOL Event
See More Headlines

RVPHW Stock Analysis - Frequently Asked Questions

Reviva Pharmaceuticals' stock was trading at $1.43 on January 1st, 2024. Since then, RVPHW stock has decreased by 90.4% and is now trading at $0.1375.
View the best growth stocks for 2024 here
.

Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RVPHW
Web
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:RVPHW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners